IP Library › Granted Patent US 7,781,425
Granted Patent B2
US 7,781,425 · App. 10/589,814 · Granted Aug 24, 2010

Guanidine compound and asymmetric reaction using the same

Assignee: Takasago International Coporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,781,425
App. No.
10/589,814
Granted
Aug 24, 2010
Kind
B2
Abstract

A guanidine compound having a biaryl skeleton represented by the following formula (1), which is useful as a catalyst for various asymmetric reactions. (wherein R 1 , R 2 and R 3 each independently represent a hydrogen atom, a hydrocarbon group optionally having substituent(s), or a heterocyclic group optionally having substituent(s); R 4 to R 15 each independently represent a hydrogen atom, a hydrocarbon group optionally having substituent(s), a heterocyclic group optionally having substituent(s), a hydroxy group, an alkoxy group optionally having substituent(s), an aryloxy group optionally having substituent(s), an acyl group, an alkoxycarbonyl group optionally having substituent(s), an aryloxycarbonyl group optionally having substituent(s), a carbamoyl group optionally having substituent(s), an alkylthiocarbonyl group optionally having substituent(s), an arylthiocarbonyl group optionally having substituent(s), a carboxyl group, an alkylthio group optionally having substituent(s), an arylthio group optionally having substituent(s), an amino group or a substituted amino group, or a substituted silyl group; or in any combination of R 1 to R 15 , these substituents may be taken together to form a ring; and X 1 to X 8 represent a hydrogen atom or a nitrogen atom, provided that, in the case of a nitrogen atom, there is no substituent on X 1 to X 8 .

Claims (6)

1. A guanidine compound having a biaryl skeleton represented by the following formula (Z):

wherein

R 1 , R 2 and R 3 each independently represent a hydrogen atom, a hydrocarbon group optionally having substituent(s), or a heterocyclic group optionally having substituent(s);

R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 each independently represent a hydrogen atom, a hydrocarbon group optionally having substituent(s), a heterocyclic group optionally having substituent(s), a hydroxy group, an alkoxy group optionally having substituent(s), an aryloxy group optionally having substituent(s), an acyl group, an alkoxycarbonyl group optionally having substituent(s), an aryloxycarbonyl group optionally having substituent(s), a carbamoyl group optionally having substituent(s), an alkylthiocarbonyl group optionally having substituent(s), an arylthiocarbonyl group optionally having substituent(s), a carboxyl group, an alkylthio group optionally having substituent(s), an arylthio group optionally having substituent(s), an amino group or a substituted amino group, a substituted silyl group or a halogen atom.

2. The guanidine compound according to claim 1 , which is optically active.

3. The optically active guanidine compound according to claim 2 , which is an optically active form due to axial chirality.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2006
From: TERADA, MASAHIRO; UBE, HITOSHI; YOKOYAMA, SHIGEKO; SHIMIZU, HIDEO
To: TAKASAGO INTERNATIONAL CORPORATION
Reel/Frame 018318/0571 →
Priority Claims (1)
JP 2004-041181 · Feb 18, 2004 · national
Continuity (1)
Related Publication 20080154036A1 · Jun 26, 2008